Skip to main content
. 2019 Oct 25;11(11):2581. doi: 10.3390/nu11112581

Figure 1.

Figure 1

Experimental design. BW, body weight; SBP, systolic BP; SNA, sympathetic nerve activity; BRS, baroreflex response sensitivity, NO, nitric oxide; NTS, nucleus tractus solitarii; TG, triglyceride; PF, PF04620110 (DGAT1 inhibitor).